John Maraganore, Ph.D.

John Maraganore, Ph.D.

DirectoratKymera Therapeutics· In proxies 2023–2025

John Maraganore, Ph.D. sits on 6 public boards.

Boards1

  • Kymera TherapeuticsDirector · 3 yr on the boardIndependentCompensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Kymera TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +400%
  2. Beam Therapeutics Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Rapport Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Takeda PharmaceuticalsPublic company
    • Director? – PresentNo stock prices for these years
  5. ProKidney CorpPublic company · 2 yr
    • Director2022 – 2024 · 2 yrNo stock prices for these years
  6. Agios Pharmaceuticals, Inc.Public company · 13 yr
    • Director2010 – 2023 · 13 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?